Lyell Immunopharma
LYEL
#8596
Rank
โ‚ฌ0.12 B
Marketcap
0,42ย โ‚ฌ
Share price
-0.04%
Change (1 day)
-77.99%
Change (1 year)

Operating Margin for Lyell Immunopharma (LYEL)

Operating Margin as of April 2025 (TTM): -562,285.00%

According to Lyell Immunopharma's latest financial reports and stock price the company's current Operating Margin is -562,285.00%. At the end of 2024 the company had an Operating Margin of -562,285.25%.

Operating Margin history for Lyell Immunopharma from 2020 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-562,285.25%211.54%
2023-180,486.15%83365.9%
2022-216.24%-90.8%
2021-2,349.47%-10.88%
2020-2,636.31%-86.61%
2019-19,692.09%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.